AMA
Wei T, Duan Z, Chen H, Xiang Z, Li C. Assessment of adalimumab used in a patient with
hemorrhagic rheumatoid neutrophilic dermatosis. Postępy Dermatologii i Alergologii/Advances in Dermatology and Allergology. 2026. doi:10.5114/ada.2026.159113.
APA
Wei, T., Duan, Z., Chen, H., Xiang, Z., & Li, C. (2026). Assessment of adalimumab used in a patient with
hemorrhagic rheumatoid neutrophilic dermatosis. Postępy Dermatologii i Alergologii/Advances in Dermatology and Allergology. https://doi.org/10.5114/ada.2026.159113
Chicago
Wei, Tianqi, Zhimin Duan, Hao Chen, Zhi Xiang, and Chengrang Li. 2026. "Assessment of adalimumab used in a patient with
hemorrhagic rheumatoid neutrophilic dermatosis". Postępy Dermatologii i Alergologii/Advances in Dermatology and Allergology. doi:10.5114/ada.2026.159113.
Harvard
Wei, T., Duan, Z., Chen, H., Xiang, Z., and Li, C. (2026). Assessment of adalimumab used in a patient with
hemorrhagic rheumatoid neutrophilic dermatosis. Postępy Dermatologii i Alergologii/Advances in Dermatology and Allergology. https://doi.org/10.5114/ada.2026.159113
MLA
Wei, Tianqi et al. "Assessment of adalimumab used in a patient with
hemorrhagic rheumatoid neutrophilic dermatosis." Postępy Dermatologii i Alergologii/Advances in Dermatology and Allergology, 2026. doi:10.5114/ada.2026.159113.
Vancouver
Wei T, Duan Z, Chen H, Xiang Z, Li C. Assessment of adalimumab used in a patient with
hemorrhagic rheumatoid neutrophilic dermatosis. Postępy Dermatologii i Alergologii/Advances in Dermatology and Allergology. 2026. doi:10.5114/ada.2026.159113.
